BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12716375)

  • 1. Expression of cox-2, tie-2 and glycodelin by megakaryocytes in patients with chronic myeloid leukaemia and polycythaemia vera.
    Zetterberg E; Lundberg LG; Palmblad J
    Br J Haematol; 2003 May; 121(3):497-9. PubMed ID: 12716375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of blood vessels in bone marrow from patients with chronic myeloid leukemia and polycythemia vera.
    Zetterberg E; Lundberg LG; Palmblad J
    Scand J Clin Lab Invest; 2004; 64(7):641-7. PubMed ID: 15513321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microplanimetric studies on megakaryocytes in chronic granulocytic leukaemia and polycythaemia vera.
    FRANZEN S; STRENGER G; ZAJICEK J
    Acta Haematol; 1961; 26():182-93. PubMed ID: 13894731
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders.
    Bock O; Schlué J; Mengel M; Büsche G; Serinsöz E; Kreipe H
    J Pathol; 2004 May; 203(1):609-15. PubMed ID: 15095485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human megakaryocyte polyploidization is associated with a decrease in GPIIIA expression.
    Baatout S; Chatelain B; Staquet P; Symann M; Chatelain C
    Anticancer Res; 1999; 19(6B):5187-9. PubMed ID: 10697532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
    Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
    J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of Tie-1 protein expression in patients with early chronic phase chronic myeloid leukemia.
    Verstovsek S; Kantarjian H; Manshouri T; O'Brien S; Faderl S; Talpaz M; Cortes J; Albitar M
    Cancer; 2002 Mar; 94(5):1517-21. PubMed ID: 11920509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polycythaemia rubra vera-1 gene is constitutively expressed by bone marrow cells and does not discriminate polycythaemia vera from reactive and other chronic myeloproliferative disorders.
    Bock O; Serinsöz E; Neusch M; Schlué J; Kreipe H
    Br J Haematol; 2003 Nov; 123(3):472-4. PubMed ID: 14617008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets.
    Rocca B; Secchiero P; Ciabattoni G; Ranelletti FO; Catani L; Guidotti L; Melloni E; Maggiano N; Zauli G; Patrono C
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7634-9. PubMed ID: 12032335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCR-ABL1- positive chronic myeloid leukemia with erythrocytosis presenting as polycythemia vera: a case report.
    Cornea MI; Levrat E; Pugin P; Betticher DC
    J Med Case Rep; 2015 Apr; 9():30. PubMed ID: 26187587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-1, but not -2, is upregulated in NB4 leukemic cells and human primary promyelocytic blasts during differentiation.
    Rocca B; Morosetti R; Habib A; Maggiano N; Zassadowski F; Ciabattoni G; Chomienne C; Papp B; Ranelletti FO
    Leukemia; 2004 Aug; 18(8):1373-9. PubMed ID: 15190260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic role and regulation of cyclooxygenase-2 (COX-2) in ovarian carcinoma].
    Denkert C
    Zentralbl Gynakol; 2004 Oct; 126(5):326-7. PubMed ID: 15478052
    [No Abstract]   [Full Text] [Related]  

  • 14. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.
    James C; Ugo V; Le Couédic JP; Staerk J; Delhommeau F; Lacout C; Garçon L; Raslova H; Berger R; Bennaceur-Griscelli A; Villeval JL; Constantinescu SN; Casadevall N; Vainchenker W
    Nature; 2005 Apr; 434(7037):1144-8. PubMed ID: 15793561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ultrastructure of megakaryocytes in polycythaemia vera and chronic granulocytic leukaemia.
    Lagerlöf B; Franzén S
    Acta Pathol Microbiol Scand A; 1972; 80(1):71-83. PubMed ID: 4508341
    [No Abstract]   [Full Text] [Related]  

  • 16. The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms.
    Tadmor T; Bejar J; Attias D; Mischenko E; Sabo E; Neufeld G; Vadasz Z
    Am J Hematol; 2013 May; 88(5):355-8. PubMed ID: 23494965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis.
    Vannucchi AM; Pancrazzi A; Guglielmelli P; Di Lollo S; Bogani C; Baroni G; Bianchi L; Migliaccio AR; Bosi A; Paoletti F
    Am J Pathol; 2005 Sep; 167(3):849-58. PubMed ID: 16127162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of cyclooxygenase-2 and tumor angiogenesis in human gastric cancer.
    Koga T; Shibahara K; Kabashima A; Sumiyoshi Y; Kimura Y; Takahashi I; Kakeji Y; Maehara Y
    Hepatogastroenterology; 2004; 51(60):1626-30. PubMed ID: 15532792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Importance of immunomorphometric evaluation of the size and number of megakaryocytes in normal and pathologic bone marrow].
    Marisavljević D; Rolović Z; Mitrović D
    Srp Arh Celok Lek; 1993; 121(3-7):57-61. PubMed ID: 7716637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Megakaryocytopoiesis in myeloproliferative disorders].
    Podolak-Dawidziak M
    Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.